Skip to main content
logo
Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.6152
-0.0090 (-1.44%)
Oct 19, 2026, 1:27 PM EDT - Market open

Tempest Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
101436851236
Market Cap Growth
-80.33%-61.17%-57.00%600.22%-66.85%-
Enterprise Value
17153295-14-4
Last Close Price
0.622.8710.8557.2014.9568.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-2.121.903.160.671.01
P/TBV Ratio
-2.121.903.160.671.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-6.941.220.800.771.220.51
Net Debt / Equity Ratio
-6.220.07-0.78-0.69-0.50-0.92
Net Debt / EBITDA Ratio
-0.32-0.020.360.650.271.25
Net Debt / FCF Ratio
-0.33-0.020.450.680.291.28
Quick Ratio
0.182.332.134.174.292.59
Current Ratio
0.382.502.214.294.533.44
Return on Equity (ROE)
-931.14%-203.63%-182.35%-131.42%-131.70%-104.76%
Return on Assets (ROA)
-79.37%-56.86%-56.43%-37.31%-36.29%-35.10%
Return on Capital Employed (ROCE)
-417.90%-195.20%-154.10%-69.10%-89.30%-50.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-392.01%-185.72%-114.89%-34.82%-295.25%-77.57%
FCF Yield
-200.79%-189.66%-91.88%-32.50%-261.55%-71.51%
Buyback Yield / Dilution
-186.97%-93.35%-80.99%-33.49%-204.70%-709.63%
SEC Filings: 10-K · 10-Q